Impact of Obesity on Acute Kidney Injury Incidence Among Patients Treated with Piperacillin–Tazobactam and Vancomycin

BACKGROUND: Obesity is associated with worse patient outcomes in a variety of clinical scenarios. It is unclear from previous research if obesity is associated with increased acute kidney injury (AKI) among patients receiving concomitant piperacillin-tazobactam (TZP) and vancomycin (VAN). METHODS: C...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutter, W Cliff, Hall, Ronald, Burgess, David S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631612/
http://dx.doi.org/10.1093/ofid/ofx163.798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631612/
http://dx.doi.org/10.1093/ofid/ofx163.798

Ejemplares similares